Učitavanje...
Diazoxide-associated pulmonary hypertension in a patient with noncompaction cardiomyopathy
Development of pulmonary hypertension after initiation of diazoxide for the treatment of neonatal hyperinsulinemic hypoglycemia is a rare, but previously described association. Risk factors for development of diazoxide-associated pulmonary hypertension include lower gestational age and congenital he...
Spremljeno u:
| Izdano u: | Pulm Circ |
|---|---|
| Glavni autori: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7869162/ https://ncbi.nlm.nih.gov/pubmed/33614015 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045894020987117 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|